Summary
Although the glycoprotein IIb/IIIa receptor inhibitors have improved outcomes of patients with acute coronary syndrome (ACS), therapy with these agents may cause thrombocytopenia with bleeding complications. This adverse effect is seemed to be rare with tirofiban. In this report, we describe a case of acute profound thrombocytopenia within two hours of tirofiban administration and review the differential diagnosis and the management of thrombocytopenia.
Similar content being viewed by others
References
Boersma E, Harrington EA, Moliterno DJ, et al. (2002) Platelet glycoprotein IIb/IIIa inhibi-tors in acute coronary syndromes: a meta-analysis of all majr randomized trials. Lancet 359:189–198
Karvouni E, Katritsis DG, Ioannidis J (2003) Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 41:26–32
RESTORE Investigators (1997) Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96:1445–1453
PRISM Study Investigators (1998) A comparision of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338:1498–1505
PRISM-PLUS Study Investigators (1998) Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non Q-wave myocardial infarction. N Engl J Med 338:1488–1497
Bougie DW, Wilker PR, Wuitschick ED, et al. (2002) Acute thrombocytopenia after treatment with tirofiban or ebtifibatide is associated with antibodies spesific for ligand-occupied GPIIb/IIIa. Blood 100:2071–2076
BednarB, Cook JJ, Holahan MA, et al. (1999) Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood 94:587–599
Berkowitz SD, Harrington RA, Rund MM, et al. (1997) Acute profound thrombocytopenia after c7E3 Fab (Abciximab) therapy. Circulation 95:809–813
Holmes HB, Kabbani S, Watkins M, et al. (2000) Abciximab-associated pseudothrom-bocytopenia. Circulation 101:938–939
Warkentin TE, Aird WC, Rand JH (2003) Platelet-endothelial intereactions:sepsis, HIT and antiphospholipid syndrome. Hematology 497–519
Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrompocytopenia. N Engl J Med 344:1286–1292
Llevadot J, Coulter SA, Giugliano RP (2000) A practical approach to diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors. J Thromb Thrombolysis 9:175–180
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demirkan, B., Guray, Y., Guray, U. et al. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban : A case report. J Thromb Thrombolysis 22, 77–78 (2006). https://doi.org/10.1007/s11239-006-7789-1
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-7789-1